Literature DB >> 15876300

The respiratory system in connective tissue disorders.

B Crestani1.   

Abstract

The connective tissue disorders (also called collagen vascular diseases) represent an heterogeneous group of immunologically mediated inflammatory disorders with a large variety of affected organs besides the lungs. The respiratory system may be involved in all its components: airways, vessels, parenchyma, pleura, respiratory muscles, etc. The frequency, clinical presentation, prognosis and response to therapy vary, depending on the pattern of involvement as well as on the underlying connective tissue disorders. The subject of this review is to describe the most frequent type of lung disorders observed in patients with connective tissue disease (CTD). We will focus on the most frequent CTD: systemic lupus erythematosus, rheumatoid arthritis, scleroderma, Sjogren's syndrome, dermatopolymyositis and mixed CTD.

Entities:  

Mesh:

Year:  2005        PMID: 15876300     DOI: 10.1111/j.1398-9995.2005.00761.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  24 in total

Review 1.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

Review 2.  [Interstitial processes of the lungs in childhood].

Authors:  H Popper
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

3.  Dyspnoea in lupus.

Authors:  Jeremy Fleri Soler; Andrew Borg; Cecilia Mercieca
Journal:  BMJ Case Rep       Date:  2017-11-08

Review 4.  Inflammation-associated remodelling and fibrosis in the lung - a process and an end point.

Authors:  William A H Wallace; Paul M Fitch; A John Simpson; Sarah E M Howie
Journal:  Int J Exp Pathol       Date:  2007-04       Impact factor: 1.925

Review 5.  Pathogenic and protective roles of B cells and antibodies in patients with chronic rhinosinusitis.

Authors:  Bruce K Tan; Anju T Peters; Robert P Schleimer; Kathryn E Hulse
Journal:  J Allergy Clin Immunol       Date:  2018-05       Impact factor: 10.793

6.  Interstitial Lung Disease in Children Older Than 2 Years.

Authors:  Timothy J Vece; Leland L Fan
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

Review 7.  [Histomorphology of interstitial lung disease and pulmonary vasculitis].

Authors:  I Bittmann; K Holl-Ulrich
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

Review 8.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

9.  Lung scintigraphy with nonspecific human immunoglobulin G ((99m)Tc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT).

Authors:  Ch Kostopoulos; J Koutsikos; C Toubanakis; L A Moulopoulos; Ch Mamoulakis; E Gialafos; P P Sfikakis; Ch Zerva; M Mavrikakis; A Leondi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236

Review 10.  A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Tracy J Doyle; Joyce S Lee; Paul F Dellaripa; James A Lederer; Eric L Matteson; Aryeh Fischer; Dana P Ascherman; Marilyn K Glassberg; Jay H Ryu; Sonye K Danoff; Kevin K Brown; Harold R Collard; Ivan O Rosas
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.